The management of anticoagulant toxicity involves several strategies. Monitoring the International Normalized Ratio (INR) is crucial for patients on warfarin to ensure therapeutic levels. In cases of overdose, Vitamin K can be administered to reverse warfarin's effects. For DOACs, specific reversal agents like idarucizumab for dabigatran and andexanet alfa for factor Xa inhibitors are available.
